Virology News and Research

Latest Virology News and Research

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Hubris is the greatest danger in wealthy countries -; a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.

14 Oct 2014

Cornell University researchers reveal details of how MERS-CoV enters host cells

Cornell University researchers have uncovered details of how the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) enters host cells, and offer possible new avenues for treatment.

14 Oct 2014

FDA approves new hepatitis C drug, Harvoni

Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.

14 Oct 2014

Texas health worker contracts Ebola, fueling questions about training and preparedness

The case, the first in which the disease was transmitted in the U.S., raises questions about whether regular hospitals around the country are ready to safely deal with the virus.

13 Oct 2014

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

In 2011, households with at least one member between ages 50 and 64 spent 8 percent of their total budget on health items, compared with 19 percent for those age 85 or over.

13 Oct 2014

Viewpoints: Effects of health law; conquering Ebola

In case you don't follow me on Twitter, here it is: The Affordable Care Act has already helped slow the rate of growth in health-care costs across the board, putting more money in Americans' pockets and bringing down projected deficits even as millions more people sign up for health insurance and receive access to Medicaid.

13 Oct 2014

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.

12 Oct 2014

Social networking strategies encourage more at risk people to get tested for HIV

Old-school face-to-face social networking is a more effective way to identify people with HIV than the traditional referral method, suggests research being presented at IDWeek 2014.

12 Oct 2014

Maker of experimental Ebola drug scales up

The manufacturer of the experimental Ebola drug ZMapp says it has put other business on hold since August to boost production of the medication. Meanwhile, news outlets look at the government's authority to screen airline travelers, the House action to release additional funding for disease-fighting efforts and the Dallas hospital's defense of its treatment of the West African man who died of the disease this week.

12 Oct 2014

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

New Ebola research demonstrates that quick and forceful implementation of control interventions are necessary to control outbreaks and avoid far worse scenarios.

10 Oct 2014

Primerdesign develops simple diagnostic test solution to contain 2014 Ebola outbreak

High-tech British company Primerdesign Ltd, a spin-off company from the University of Southampton, has developed a fast and simple diagnostic test solution specific to the 2014 Ebola outbreak.

10 Oct 2014

Ebola screening and education stepped up amid fears of spiralling epidemic

The recent occurrences of Ebola cases outside Africa has led to fears of a global epidemic. The US Centers for Disease Control and Prevention (CDC) has estimated that the number of infections could rise to up to 1.4 million people by early next year without a massive global intervention to contain the virus.

10 Oct 2014

Views on giving flu shot to younger children

It's a common question parents ask themselves this time of year: Does my child really need a flu shot? Though the flu may seem harmless, the truth is on average 20,000 children age 5 and younger are hospitalized due to flu symptoms each year.

10 Oct 2014

Viewpoints: Walmart and Obamacare; negative views continue of health law; Ebola preparedness

Walmart announced today that as of the beginning of next year it will be dropping health insurance for 30,000 employees who work less than 30 hours per week. Many liberals will react to the news by saying that it's just a profit-hungry corporation once again screwing over its employees. Conservatives are likely to say that this just shows what a mess Obamacare has created and why it should be repealed (Paul Waldman, 10/8).

10 Oct 2014

U.S. to step up Ebola screening at 5 major airports

Passengers arriving from West Africa will have their temperatures taken at the airports. Meanwhile, questions are emerging about the care given to Thomas Eric Duncan, the Texas Ebola patient who died Wednesday, including why he was initially released from the hospital.

10 Oct 2014

First study of promising Ebola vaccine commenced in West Africa

Professor Myron M. Levine, MD, Director of the Center for Vaccine Development at the University of Maryland School of Medicine, and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali and the Ministry of Health of Mali, have begun a clinical trial in health care workers (and other front-line workers) to evaluate a promising experimental Ebola vaccine.

10 Oct 2014

European experts publish common vision of priorities for marine research

Some 340 European scientists, policy-makers and other experts representing 143 organizations from 31 countries spoke with one voice today, publishing a common vision of today's most pressing marine-related health and economic threats and opportunities.

9 Oct 2014

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.

9 Oct 2014

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.

9 Oct 2014

Virology News and Research

Latest Virology News and Research

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Viewpoints: Ebola myths; Sen. McCain's 'opportunistic alarmism'; Gov. Jindal on CDC's misspent resources

Cornell University researchers reveal details of how MERS-CoV enters host cells

FDA approves new hepatitis C drug, Harvoni

Texas health worker contracts Ebola, fueling questions about training and preparedness

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

Viewpoints: Effects of health law; conquering Ebola

Molecular diagnostics and blood screening systems: an interview with Dr Bos and Dr Koppelman

Social networking strategies encourage more at risk people to get tested for HIV

Maker of experimental Ebola drug scales up

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

Primerdesign develops simple diagnostic test solution to contain 2014 Ebola outbreak

Ebola screening and education stepped up amid fears of spiralling epidemic

Views on giving flu shot to younger children

Viewpoints: Walmart and Obamacare; negative views continue of health law; Ebola preparedness

U.S. to step up Ebola screening at 5 major airports

First study of promising Ebola vaccine commenced in West Africa

European experts publish common vision of priorities for marine research

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production